Peer Review History

Original SubmissionAugust 5, 2021
Decision Letter - R. Mark Wooten, Editor

PONE-D-21-25422Is the presence of Leptospira in the environment merely random? An epidemiological explanation based on serial analysis of water samplesPLOS ONE

Dear Dr. Agampodi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that this manuscript has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. While all reviewers thought that the study has merit, many aspects of the study were not described well enough for the reader to understand how the data was acquired, the rigor applied to statistics, and how the data was interpreted.  Thus, for this manuscript to be reconsidered for publication, it will be important for the authors to address ALL the comments brought forward by the reviewers.

 ==

Please submit your revised manuscript by December 30, 2021. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

R. Mark Wooten, Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. "Funding Information and Financial Disclosure sections do not match:

We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“JW and IS are partially supported by US Public Service Grant U19AI115658. The sample analysis was funded through the Faculty of Medicine and Allied Sciences annual publication award received by the first and last authors. All the other costs are self-funded.

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 “SA: JW and IS are partially supported by US Public Service Grant U19AI115658. The sample analysis was funded through the Faculty of Medicine and Allied Sciences annual publication award received by the first and last authors. All the other costs are self-funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. Please note that in order to use the direct billing option the corresponding author must be affiliated with the chosen institute. Please either amend your manuscript to change the affiliation or corresponding author, or email us at plosone@plos.org with a request to remove this option.

5. We note that Figures 2,3 and 4 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

 We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figures 2, 3 and 4 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

 Please upload the completed Content Permission Form or other proof of granted permissions as an ""Other"" file with your submission.

 In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

 USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: In this epidemiologic study the authors collected soil and water samples from several regions (wet, dry and semi-dry) of Sri Lanka based on probable exposure history of confirmed leptospirosis patients and tested it by PCR. There are few leptospirosis epidemiologic studies from Sri Lanka. From the wet area 2/12 water sites were positive. From the dry area 1 well in areas of high human contact were positive. A specific positive site in the dry area was chosen to do serial sample testing from 10 wells surrounding a positive well (nr 9) and they found that at different times 4 to 6 of the 10 wells in that site were positive for Leptospira. The work has merit but as described in this paper is very difficult to follow and the abstract does not capture the essence or importance of the work done. The description of the method to collect the samples including a better flow chart, figures, tables and writing to need to be comprehensively revised.

Other comments:

Methods: If the primers detect nonpathogenic Leptospira species, what is the rationale of detecting virulent species in the water and soil samples?

Study design and presentation of results: Very confusing descriptions of all data.

Throughout the paper (including abstract) avoid using Components 1, 2, 3 and just define the sites as 1-X nr of water and soil samples from Wet area, 2- X nr of Wells in Dry Area, 3 – 10 wells surrounding a positive well in dry area.

Discussion: down the claims of positive Leptospiral transmission routes or correlations with disease hotspots since no clinical data is shown.

It is difficult to design any prophylactic measures based on an epidemiological study. Reservoir based studies or other specific animal study can therefore open such avenues to search for a better alternatives than available Doxycycline.

Reviewer #2: This is a nice manuscript describing findings of Leptospira in the environment, adding to our knowledge of transmission of Leptospira in the environment.

Specific comments:

The authors use "random" to describe Leptospira in the environment, but I'm not sure that's the correct term. Maybe transient? Or variable? Maybe conditions have to be ideal to reach levels above the limit of detection, and with clear correlations of lepto cases in humans and rainy seasons, and as shown in this study, proximity to a lake where feral animals are prevalent, I'm not sure "random" should be used.

Can the authors justify why they tossed the first centrifuged water pellet? It's mentioned in limitations that they may have lost some lepto with the pellet. Also, a DNA blood mini kit was used for environmental water - can the authors justify the extraction kit use, or were they able to determine whether or not PCR inhibitors were present?

Can the authors describe in better detail the definition of PCR positivity? It's not clear to me how many "replicates" were done, and whether the replicates were in the PCR reaction or replicate samples.

What is the difference between an "abundant paddy field" and a paddy field (line 183)? More vegetation? Larger?

It might be helpful in the results section to clarify that the soil sequencing detected both pathogenic and non-pathogenic Leptospira, and that non-pathogenic Leptospira are considered ubiquitous.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Respond to reviewers document is attached separately.

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - R. Mark Wooten, Editor

PONE-D-21-25422R1The variable presence of Leptospira in the environment; An epidemiological explanation based on serial analysis of water samplesPLOS ONE

Dear Dr. Agampodi,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The requested edits are minor and, if corrected, will likely result in acceptance for publication.  We look forward to receiving your revised manuscript.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

R. Mark Wooten, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Abstract

Line 23: define the classic triad

Methods:

Line 105 and others: Purposive? What does this word mean?

Discussion

Line 279: How much is “a satisfactory concentration of Leptospira needed in the environment”.

Line 309: This concept of intermittent positivity versus repetitive contamination should be mentioned in the abstract.

Reviewer #2: Thank you, the revision provided clarity and I think the manuscript provides valuable information about Leptospira in the environment in an endemic area. I have only one small comment, to de-capitalize "leptospirosis" in the middle of a sentence.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 2

Comment - Please review your reference list to ensure that it is complete and correct.

Reply - Done

Comment - If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

Reply - No retracted papers are cited.

Comment - Abstract

Line 23: define the classic triad

Reply - Thank you very much for the comment. We included the epidemiological triad within brackets in the given place.

Comment - Methods:

Line 105 and others: Purposive? What does this word mean?

Reply - Thank you very much for the comment. We understand the concern. We used the term ‘purposive’ to indicate the non-probability sampling technique. However, the term purposive is more general.

The term purposive was used in two places to explain the sample selection technique of two components of the study.

Actually, we selected the sites for the first component based on the probable sites of contamination by leptospirosis patients. These were during our clinical studies, investigators past experiences or the experiences of the physicians.

We selected the sites for the second component considering the possibility of daily exposure by the humans.

For, better clarity, we changed the sentences as follows.

“For the water samples, water sources were selected purposefully based on the probable sites of contamination of diagnosed leptospirosis patients. Sampling was conducted at 12 sites representing all three climatic zones: dry, wet, and intermediate.”

“For the second component, water collection sites were selected purposefully considering the possibility of daily human contacts.”

Comment - Discussion

Line 279: How much is “a satisfactory concentration of Leptospira needed in the environment”.

Reply - I humbly thank you for this comment. This is something we can’t give an exact answer and this depends on several factors as shown in the last figure.

However, we needed to explain that the higher concentration due to recent animal contamination could be a factor associated with this.

Further studies on satisfactory concentration could be an interesting research area to explore.

We added the following sentence at the end of the paragraph.

“Studies on required minimal leptospira concentration in the environment could be new research area to be explored.”

Comment - Line 309: This concept of intermittent positivity versus repetitive contamination should be mentioned in the abstract.

Reply - Thank you very much for the nice suggestion. We added the following sentence to the abstract.

“This intermittent nature of positivity could be explained by the repetitive contamination by animal urine.”

Comment - Thank you, the revision provided clarity and I think the manuscript provides valuable information about Leptospira in the environment in an endemic area. I have only one small comment, to de-capitalize "leptospirosis" in the middle of a sentence

Reply - Thank you very much. We did the changes in the manuscript.

Attachments
Attachment
Submitted filename: Reply to reviewers plos one soil.docx
Decision Letter - R. Mark Wooten, Editor

The variable presence of Leptospira in the environment; An epidemiological explanation based on serial analysis of water samples

PONE-D-21-25422R2

Dear Dr. Agampodi,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

R. Mark Wooten, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - R. Mark Wooten, Editor

PONE-D-21-25422R2

The variable presence of Leptospira in the environment; An epidemiological explanation based on serial analysis of water samples

Dear Dr. Agampodi:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. R. Mark Wooten

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .